Der Maus Monoklonal Anti-LRPAP1-Antikörper wurde für WB, IHC, IF und LBA validiert. Er ist geeignet, LRPAP1 in Proben von Human zu detektieren. Es ist 1 Publikation verfügbar.
LRPAP1
Reaktivität: Human
IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
IHC: 1:20
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
reconstitue with 1 mL deionized water
Konzentration
0.05 mg/mL
Buffer
PBS, pH 7.4, 0.5 % BSA
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
2-8°C (after addition of conserving agent), extended storage at -20°C, avoid repeated freeze-thaw cycles
Kounnas, Argraves, Strickland: "The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330." in: The Journal of biological chemistry, Vol. 267, Issue 29, pp. 21162-6, (1992) (PubMed).
Target
LRPAP1
(Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))
Andere Bezeichnung
RAP
Hintergrund
7F1 reacts with the 39 kDa RAP protein, which is cosynthesized with human LRP/ α 2 MR (low density lipoprotein receptor-related protein / α 2 -macro- globulin receptor). It inhibits the binding of ligands, e.g. tPA, uPA, VLDL, liproprotein lipase, and α 2